Sativex + Sativex + Sativex + Sativex

Phase 1Completed
1 views this week 0 watching💤 Quiet
Interest: 26/100
26
Hype Score

Development Stage

Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Food Effect

Conditions

Food Effect

Trial Timeline

Jan 1, 2008 → Feb 1, 2008

About Sativex + Sativex + Sativex + Sativex

Sativex + Sativex + Sativex + Sativex is a phase 1 stage product being developed by Jazz Pharmaceuticals for Food Effect. The current trial status is completed. This product is registered under clinical trial identifier NCT01322464. Target conditions include Food Effect.

What happened to similar drugs?

2 of 3 similar drugs in Food Effect were approved

Approved (2) Terminated (1) Active (0)
OmalizumabNovartisApproved
Omalizumab InjectionRocheApproved

Hype Score Breakdown

Clinical
6
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01322464Phase 1Completed